Proqr Therapeutics B.V. (PRQR)

[JohnLocke101]

I’m not an ophthalmologist (calling Dr. Rand Paul) but listening in to the call sounds awfully positive. Safe and well tolerated with no SAE’s. Meeting all endpoints. It was with a single injection too with the data showing a second dosing at around 6 months might give added benefit.

This next P2/3 trial (x2 parallel studies) is going to be really interesting. End of 2021. I believe he said the trials would be 18 months long with a possible interim readout at 12 months.

Edit - compelling presentation. I may stick around longer than I anticipated. Good problems.